Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 194

Sort by

Sort Order Select

Journal Articles

Comprehensive Analysis of Genotype and Prior Exposures in Therapy-Related Myeloid Neoplasms (t-MNs)

Veronica A Guerra, MD, Yan Yuanqing, PhD, Joanne Hsu, BS, Feng Wang, PhD, Mansour Alfayez, MD, Kiyomi Morita, MD, Xingzhi Song, PhD, Courtney D. DiNardo, MD MSc, Marina Y Konopleva, MD PhD, Gautam M. Borthakur, MD, Guillermo Montalban Bravo, MD, Jianhua Zhang, PhD, Latasha Little, BS, Curtis Gumbs, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD, Andrew Futreal, PhD, Koichi Takahashi, MD

Blood (2019) 134 (Supplement_1): 458.

https://doi.org/10.1182/blood-2019-127498

Published: 2019

Journal Articles

TP53 Abnormality in Myelodysplastic Syndrome

Fei Huang, Yu Chen, Yuxing Zhu, Chun Qiao, Sixuan Qian, Jianyong Li, MD, Wenyi Shen, MD

Blood (2019) 134 (Supplement_1): 5410.

https://doi.org/10.1182/blood-2019-128054

Published: 2019

Journal Articles

Molecular Dissection of Del(5q): Distinction between Primary and Secondary Del(5q) and Pathogenetic Implications

Vera Adema, PhD, Laura Palomo, Cassandra M Kerr, MS, Wencke Walter, PhD, Bartlomiej Przychodzen, Stephan Hutter, PhD, Thomas Laframboise, PhD, María Díez-Campelo, MD PhD, Mar Mallo, PhD, Aziz Nazha, MD, Blanca Xicoy, MD MSc, Manja Meggendorfer, PhD, Hetty E. Carraway, MD MBA, Claudia Haferlach, MD, Mikkael A. Sekeres, MD MS, Valeria Visconte, PhD, Torsten Haferlach, MD, Francesc Sole, PhD, Jaroslaw P. Maciejewski, MD PhD

Blood (2019) 134 (Supplement_1): 4221.

https://doi.org/10.1182/blood-2019-129292

Published: 2019

Journal Articles

Clinical and Molecular Characteristics of DDX41 -Mutated Patients in a Large Cohort of Sporadic MDS/AML

Marie Sebert, MD, Marie Passet, PharmD, Anna Raimbault, PhD, Samuel Quentin, Nadia Vasquez, Ramy Rahmé, Emmanuel Raffoux, Flore Sicre De Fontbrune, MD PhD, Regis Peffault De Latour, Raphael Itzykson, MD PhD, Pierre Fenaux, MD PhD, Jean Soulier, MDPhD, Lionel Ades, MD PhD, Emmanuelle Clappier, PhD PharmD

Blood (2018) 132 (Supplement 1): 797.

https://doi.org/10.1182/blood-2018-99-110668

Published: 2018

Journal Articles

MMP9 Inhibition Rescues the Erythroid Defect in RPS14-Deficient Del(5q) MDS Models

Minyoung Youn, PhD, Haigen Huang, PhD, Cheng Chen, Sharon Kam, BS, Mark C Wilkes, Hee-Don Chae, PhD, Anupama Narla, MD, Shuo Lin, PhD, Kathleen M. Sakamoto, MD PhD

Blood (2018) 132 (Supplement 1): 756.

https://doi.org/10.1182/blood-2018-99-117508

Published: 2018

Journal Articles

Elevated Labile Plasma Iron (LPI) Levels in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Are Associated with Decreased Quality of Life and Reduced Survival

Blood (2018) 132 (Supplement 1): 4392.

https://doi.org/10.1182/blood-2018-99-118070

Published: 2018

Journal Articles

Should Myelodysplastic Syndromes in Very Old Patients be More Actively Managed? Clinical Characteristics, Management and Outcomes for Patients 85 Years and Older

Laura McDonald, MB MRCPI, Peter McCarthy, MB BCh BAO, Mohammad Khan, MD, Patrick Hogan, MB BCh BAO, Eileen C. Kelleher, MD, Philip Murphy, MD, John Quinn, MD PhD, Ronan Desmond, MD, Johnny McHugh, MB, FRPATH, Melanie Strickland, BNS, Mary Cahill, MD, Su Wai Maung, MRCP, MBBS, Clodagh Keohane, MD, Desmond O'Neill, MD, Daniel Ryan, MD, Vitaliy Mykytiv, MD, Helen Enright, MD

Blood (2018) 132 (Supplement 1): 5515.

https://doi.org/10.1182/blood-2018-99-113290

Published: 2018

Journal Articles

Myelodysplastic Syndromes with Isolated 20q Deletion: A New Clinical-Biological Entity?

Daniela De Benedittis, MD, Luana Fianchi, MD, Pasquale Niscola, MD PhD, Annalina Piccioni, MD, Ambra Di Veroli, MD, Alessia Campagna, MD, Stefano Mancini, MD, Nicoletta Villivà, Sara Mohamed, MD, Ida Carmosino, Marianna Criscuolo, Susanna Fenu, Maria Antonietta Aloe Spiriti, MD, Francesco Buccisano, MD, Massimo Breccia, MD, Marco Mancini, Roberto Latagliata

Blood (2018) 132 (Supplement 1): 5516.

https://doi.org/10.1182/blood-2018-99-117069

Published: 2018

Journal Articles

Ribosome Biogenesis Controls Erythroid Differentiation Via a p53-Dependent Transcriptional Checkpoint and Its Limitation By RPS14 Haploinsufficiency Results in Selective Defects in Translation

Ismael Boussaid, PharmD, Salome Le Goff, PhDstudent, Celia Floquet, Post-doc, Anna Raimbault, PharmD, PhD, Charlotte Andrieu-Soler, Emilie-fleur Gautier, PhD, Olivier Kosmider, Isabelle Hatin, PhD, Mohandas Narla, DSc, Eric Soler, PhD, Patrick Mayeux, PhD, Michaela Fontenay, MD PhD

Blood (2017) 130 (Supplement 1): 83.

https://doi.org/10.1182/blood.V130.Suppl_1.83.83

Published: 2017

Journal Articles

Measurement of Increase in Cereblon mRNA Level after Addition of Erythropoietin to Lenalidomide May Predict a Clinical Response to Combination of Both the Drugs in Patients with Lower-Risk Myelodysplastic Syndromes

Radka Bokorová, Jaroslav Polak, MSc, Arnost Kostecka, Anna Jonasova, MD PhD, Radana Neuwirtova, MD PhD, Tomas Stopka, MD PhD Assoc Proff, Marie Lauermannova, Jaroslav Cermak, MD PhD, Dana Mikulenkova, Zuzana Zemanova, PhD, Jana Brezinova, PhD, Ota Fuchs, PhD

Blood (2017) 130 (Supplement 1): 5295.

https://doi.org/10.1182/blood.V130.Suppl_1.5295.5295

Published: 2017

Journal Articles

Impact of Significant Eosinophilia in Patients with Myelodysplastic Syndromes: Single Institution Experience

Salwa S Saadeh, MBBS, Omar Alkharabsheh, MD, Darci Zblewski, CNP, Mrinal M. Patnaik, MDMBBS, Naseema Gangat, MBBS, Kebede H. Begna, MD, Hassan B. Alkhateeb, MD, Michelle A. Elliott, MD, Rong He, MD, Phuong Nguyen, MD, William J. Hogan, MBBCh, Mark R. Litzow, MD, Aref Al-Kali, MD

Blood (2017) 130 (Supplement 1): 5310.

https://doi.org/10.1182/blood.V130.Suppl_1.5310.5310

Published: 2017

Journal Articles

Risk of Venous Thrombotic Events (VTE) in Patients with Myelodysplastic Syndromes with 5q Deletion during Lenalidomide Therapy: Single Institution Experience

Omar Alkharabsheh, MD, Darci Zblewski, CNP, Naseema Gangat, MBBS, Kebede H. Begna, MD, Michelle A. Elliott, MD, Hassan B. Alkhateeb, MD, Mrinal M. Patnaik, MDMBBS, William J. Hogan, MBBCh, Mark R. Litzow, MD, Aref Al-Kali, MD

Blood (2017) 130 (Supplement 1): 5315.

https://doi.org/10.1182/blood.V130.Suppl_1.5315.5315

Published: 2017

Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome: Effect of Transplant Conditioning Regimen Intensity on Outcomes

Mary Eapen, MBBS, MS, Ruta Brazauskas, PhD, Michael T. Hemmer, MS, Waleska S Pérez, MPH, Patricia Steinart, PhD, Mary M. Horowitz, MD MS, H. Joachim Deeg, MD

Blood (2017) 130 (Supplement 1): 598.

https://doi.org/10.1182/blood.V130.Suppl_1.598.598

Published: 2017

Journal Articles

Erythrocyte Adenosine Deaminase Levels Are Elevated in Classic Diamond Blackfan Anemia but Not in the 5q- Syndrome

Anupama Narla, MD, Natalie Louise Davis, MD, Corinne LaVasseur, BA, Carolyn Wong, Bertil Glader, MD PhD

Blood (2016) 128 (22): 1501.

https://doi.org/10.1182/blood.V128.22.1501.1501

Published: 2016

Journal Articles

Outcome of Myelodysplastic Syndromes over Time in the US: A National Cancer Data Base Study from 2004-2013

Aref Al-Kali, MD, Darci Zblewski, CNP, Adam C Bartley, MS, Mrinal M Patnaik, MBBS, Naseema Gangat, MBBS, Kebede H. Begna, MD, Ayalew Tefferi, MD, Michelle Elliott, MD, William J Hogan, MBChB, Mark R. Litzow, MD, Ronald S. Go, MD

Blood (2016) 128 (22): 3604.

https://doi.org/10.1182/blood.V128.22.3604.3604

Published: 2016

Journal Articles

The First Follow-up Data Analysis of Patients with Acquired Bone Marrow Failure Harboring a Small Population of PNH-Type Cells in the Japanese, Multicenter, Prospective Study Optima

Yasutaka Ueda, MD PhD, Jun-Ichi Nishimura, MD PhD, Chiharu Sugimori, MD PhD, Kohei Hosokawa, MDPhD, Yuji Yonemura, MD PhD, Naoshi Obara, MDPhD, Hideyoshi Noji, MD PhD, Yoshihiko Nakamura, PhD, Yukari Shirasugi, MD PhD, Kiyoshi Ando, Tsutomu Shichishima, MD PhD, Haruhiko Ninomiya, MD PhD, Shigeru Chiba, MD, PhD, Tatsuya Kawaguchi, MD PhD, Yuzuru Kanakura, MD PhD, Shinji Nakao, MD PhD

Blood (2016) 128 (22): 3896.

https://doi.org/10.1182/blood.V128.22.3896.3896

Published: 2016

Journal Articles

Why Patients with 5q- Syndrome Have Thrombocythemia?

Vit Campr, MD PhD, Jan Stritesky, MD PhD, Ota Fuchs, PhD, Anna Jonasova, MD PhD, Zuzana Zemanova, PhD, Radana Neuwirtova, MD PhD

Blood (2016) 128 (22): 5533.

https://doi.org/10.1182/blood.V128.22.5533.5533

Published: 2016

Journal Articles

Prospective Evaluation of the Effect of Deferasirox on Hematologic Response in Transfusion-Dependent Patients with Low-Risk MDS and Iron Overload: The Rythmex Study

Christian Rose, MD, Olivier Fitoussi, MD, Emmanuel Gyan, MD PhD, Maya Hacini, MD, Shanti Amé, MD, Bernadette Corront, MD, Odile Beyne-Rauzy, MD PhD, Didier Innocent Adiko, MD, Elena-Anca Loppinet, MD, Nadia Ali-Ammar, MD, Eric Wattel, MD PhD, Francois Dreyfus, MD, Stéphane Cheze, MD PhD

Blood (2016) 128 (22): 2008.

https://doi.org/10.1182/blood.V128.22.2008.2008

Published: 2016

Journal Articles

New Score Prognostic System for Patients with MDS and Intermediate IPSS-R: Novel Algorithm to Distinguish Between Low and High Risk in This Subset of Patients. Results from the Spanish Group of MDS (GESMD). Gesmdi Score

Blood (2016) 128 (22): 4323.

https://doi.org/10.1182/blood.V128.22.4323.4323

Published: 2016

Journal Articles

Evolving Risk of Myelodysplastic Syndromes Among Adolescents and Young Adults Following Radiation Treatment for First Cancers in the United States, 1973 - 2014

Remco Molenaar, M.Sc., Tomas Radivoyevitch, PhD, Hetty E. Carraway, MD MBA, Jaroslaw P. Maciejewski, MD, PhD, FACP, Mikkael A Sekeres, MD MS, Sudipto Mukherjee, MD, PhD, M.P.H.

Blood (2016) 128 (22): 4334.

https://doi.org/10.1182/blood.V128.22.4334.4334

Published: 2016

NARROW

Comprehensive Analysis of Genotype and Prior Exposures in Therapy-Related Myeloid Neoplasms (t-MNs)

TP53 Abnormality in Myelodysplastic Syndrome

Molecular Dissection of Del(5q): Distinction between Primary and Secondary Del(5q) and Pathogenetic Implications

Clinical and Molecular Characteristics of DDX41 -Mutated Patients in a Large Cohort of Sporadic MDS/AML

MMP9 Inhibition Rescues the Erythroid Defect in RPS14-Deficient Del(5q) MDS Models

Elevated Labile Plasma Iron (LPI) Levels in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Are Associated with Decreased Quality of Life and Reduced Survival

Should Myelodysplastic Syndromes in Very Old Patients be More Actively Managed? Clinical Characteristics, Management and Outcomes for Patients 85 Years and Older

Myelodysplastic Syndromes with Isolated 20q Deletion: A New Clinical-Biological Entity?

Ribosome Biogenesis Controls Erythroid Differentiation Via a p53-Dependent Transcriptional Checkpoint and Its Limitation By RPS14 Haploinsufficiency Results in Selective Defects in Translation

Measurement of Increase in Cereblon mRNA Level after Addition of Erythropoietin to Lenalidomide May Predict a Clinical Response to Combination of Both the Drugs in Patients with Lower-Risk Myelodysplastic Syndromes

Impact of Significant Eosinophilia in Patients with Myelodysplastic Syndromes: Single Institution Experience

Risk of Venous Thrombotic Events (VTE) in Patients with Myelodysplastic Syndromes with 5q Deletion during Lenalidomide Therapy: Single Institution Experience

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome: Effect of Transplant Conditioning Regimen Intensity on Outcomes

Erythrocyte Adenosine Deaminase Levels Are Elevated in Classic Diamond Blackfan Anemia but Not in the 5q- Syndrome

Outcome of Myelodysplastic Syndromes over Time in the US: A National Cancer Data Base Study from 2004-2013

The First Follow-up Data Analysis of Patients with Acquired Bone Marrow Failure Harboring a Small Population of PNH-Type Cells in the Japanese, Multicenter, Prospective Study Optima

Why Patients with 5q- Syndrome Have Thrombocythemia?

Prospective Evaluation of the Effect of Deferasirox on Hematologic Response in Transfusion-Dependent Patients with Low-Risk MDS and Iron Overload: The Rythmex Study

New Score Prognostic System for Patients with MDS and Intermediate IPSS-R: Novel Algorithm to Distinguish Between Low and High Risk in This Subset of Patients. Results from the Spanish Group of MDS (GESMD). Gesmdi Score

Evolving Risk of Myelodysplastic Syndromes Among Adolescents and Young Adults Following Radiation Treatment for First Cancers in the United States, 1973 - 2014

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only